App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol Be a Pro
Get App
Select Language
Subscription
Specials
Close Ad
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
11840.50
-73.00 (-0.61%)
SENSEX
40116.06
-229.02 (-0.57%)

Auro Laboratories Ltd.

BSE: 530233 | NSE: | ISIN: INE292C01011 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info
Moneycontrol Pro TTrade Now Thomson Reuters report
| BSE 54.30 -1.30 (-2.34%) | |

BSE Live

Nov 13, 16:00
54.30 -1.30 (-2.34%)
Volume
AVERAGE VOLUME
5-Day
3,357
10-Day
5,179
30-Day
3,492
3,192

  • Prev. Close

    55.60

  • Open Price

    56.00

54.10

Today’s L/H

56.00
42.00

52 Wk L/H

77.95
44.50

L/U Price Band

66.70

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP
    54.69

  • Market Depth (13 Nov 2019)

    BUYSELL
    QTY PRICE PRICE QTY
    129 54.30 54.80 20
    1171 54.25 56.45 300
    100 54.15 56.50 100
    50 54.00 57.00 100
    450 53.95 57.25 10
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

(%)
Volume
No Data Available

  • Prev. Close

  • Open Price

Today’s L/H

52 Wk L/H

L/U Price Band

  • Bid Price (Qty.)

    ()

  • Offer Price (Qty.)

    ()

  • VWAP
    Series:
  • DELIVERY AVERAGES
    3-Day
    %
    5-Day
    %
    8-Day
    %
    Deliverables
    %
  • SMA
Auro Laboratories is not listed on NSE

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

Valuation

    • Market Cap (Rs Cr.)
      33.84
    • P/E
      6.14
    • Book Value (Rs)
      27.94
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      28.81
    • EPS (TTM)
      8.85
    • P/C
      5.19
    • Price/Book
      1.94
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      10.00
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      33.84
    • P/E
      -
    • Book Value (Rs)
      -
    • Dividend (%)
      0.00
    • Market Lot
      1
    • Industry P/E
      28.81
    • EPS (TTM)
      -
    • P/C
      -
    • Price/Book
      -
    • Dividend Yield.(%)
      -
    • Face Value (RS)
      -
    • Deliverables (%)
      -

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Simple Moving Averages
DAYS BSE NSE
Get Historical Stock Prices
Click here to view the Open, High, Low, Close, Volume and Spread data.

Forum

Community Sentiments

Data not Available

What's your call on today?

Read 0 investor views

BUY SELL HOLD
POST

Action in Auro Laboratories Ltd.

  • Technicals

    Auro Labs closes above 150-Day,200-Day Moving Average today.

    Oct 29

  • Technicals

    Auro Labs closes above 30-Day,50-Day Moving Average today.

    Oct 18

  • Technicals

    Auro Labs closes above 50-Day Moving Average of 52.83 today.

    Oct 16

  • AGM/EGM

    Auro Labs AGM on Sep 06, 2019, Announcement date: May 23, 2019

    Sep 05, 11:00

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 42.00 on BSE

    Aug 29, 14:14

  • Technicals

    Auro Labs closes above 30-Day,50-Day Moving Average today.

    Aug 16

  • Technicals

    Auro Labs closes above 30-Day,50-Day Moving Average today.

    Aug 13

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 45.00 on BSE

    Aug 05, 10:08

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 47.45 on BSE

    Aug 01, 10:02

  • Technicals

    Auro Labs closes above 50-Day,150-Day Moving Average today.

    May 17

  • Technicals

    Auro Labs closes above 30-Day,200-Day Moving Average today.

    May 10

  • Technicals

    Auro Labs closes above 30-Day Moving Average of 57.26 today.

    Mar 25

  • News

    Aurobindo buys 7 oncology injectable drugs in $300 million deal

    Jan 18, 08:00
  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 50.30 on BSE

    Jan 01, 09:18

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 51.00 on BSE

    Dec 11, 09:32

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 53.00 on BSE

    Dec 10, 09:22

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 54.25 on BSE

    Dec 07, 09:18

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 57.00 on BSE

    Dec 06, 09:44

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 57.20 on BSE

    Dec 05, 14:34

  • 52 Week Low

    Auro Labs has hit 52wk low of Rs 60.00 on BSE

    Nov 26, 11:08

News & Videos

Auro Labs Standalone March 2019 Net Sales at Rs 11.53 crore, up 2.23% Y-o-Y

Auro Labs Standalone March 2019 Net Sales at Rs 11.53 crore, up 2.23% Y-o-Y

Business | Earnings | Management Interviews
View More

News across the web

Data not available
Data not available

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE - No shares traded
NSE - No shares traded

Financials

Income Statement

  Sep 2019 Jun 2019 Mar 2019 Dec 2018 Sep 2018
Net Sales 11.10 13.72 11.53 12.28 12.55
Other Income 0.22 0.26 0.59 0.07 0.26
PBDIT 2.17 1.67 2.07 2.23 1.25
Net Profit 1.45 1.10 1.58 1.38 0.80

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 6.23 6.23
Networth 17.41 12.98
Total Debt 6.15 6.18
Net Block 14.70 13.03
Investments 0.05 0.05
Total Assets 23.55 19.15

Historical Prices

On
 Current Price %Gain / Loss
Open Price 68.00 56.00
-17.65
High Price 69.00 56.00
-18.84
Low Price 67.25 54.10
-19.55
Close Price 68.55 55.60
-18.89
Volume 845 3,192
277.75
On
 Current Price %Gain / Loss
No Record Found
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11840.50 -73.00 -0.61
SENSEX 40116.06 -229.02 -0.57
NIFTY BANK 30541.50 -574.00 -1.84
NIFTY IT 15241.00 -67.50 -0.44
S&P BSE Smallcap 13344.69 -152.83 -1.13
View More
Index Price Change %Chg
Nasdaq (Nov 13) 8,490.32 4.23 0.05
DAX (Nov 13) 13,230.07 -53.44 -0.40
FTSE (Nov 13) 7,351.21 -14.23 -0.19
CAC (Nov 13) 5,907.09 -12.66 -0.21
SGX Nifty (Nov 13) 11,891.50 26.50 0.22
View More

CORPORATE ACTION

Date Agenda
Oct 22, 2019 Quarterly Results
Aug 07, 2019 Quarterly Results
May 23, 2019 Audited Results
Jan 29, 2019 Quarterly Results
Type Dividend% Ex-Dividend date
No Dividends Information is available for Auro Laboratories
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Auro Laboratories
Old FV New FV Ex-Split
No Splits Information is available for Auro Laboratories
Ratio Premium Ex-Bonus
No Rights Information is available for Auro Laboratories
Date Agenda
Sep 06, 2019 -
Sep 29, 2018 -
Sep 29, 2017 -
Sep 26, 2016 -
Sep 25, 2015 -

Dividend Summary

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone September 2019 March 2019 December 2018 September 2018
Promoters 51.92 51.89 51.74 51.61
Pledged 0 0 0 0
FII/FPI 0 0 0 0
Total DII 12.67 13.03 13.28 13.71
Fin.Insts 0 0 0 0
Insurance Co 0 0 0 0
MF 0.01 0.01 0.01 0.01
Others DIIs 12.66 13.02 13.27 13.7
Others 35.41 35.07 34.98 34.69
Total 100 99.99 100 100.01

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Auro Labs 54.30 -2.34 77.95 42.00 33.84 46.82 4.40
Sun Pharma 411.70 -2.34 616.50 350.40 98780.62 10,303.21 816.60
Dr Reddys Labs 2755.50 -2.12 2965.20 2065.30 45781.46 10,625.50 1,277.30
Divis Labs 1665.00 -2.74 1773.00 1214.25 44200.52 4,879.66 1,332.65
Ranbaxy Labs 859.80 0.00 869.70 371.50 36598.55 6,864.94 -879.00

COMPANY OVERVIEW

Auro Laboratories Ltd is engaged in the business of manufacturing active pharmaceutical ingredients (API`s), intermediates and generic formulations.The company is primarily focused on manufacturing anti-diabetic drugs. Presently the company offers its products inthe therapeutic segment such as antihistamine, anti-fungal, anti-ulcer, anti-malaria, anti-inflammatory, antacids and others. They export their products to countries like Egypt, Germany, Malaysia, Singapore, South Africa, Brazil, Spain and United Kingdom.

COMPANY INFORMATION

  • Registered Office

    • Address

      K-56, M.I.D.C. Industrial Area, Tarapur, Boisar,,

    • City

      Palghar District

    • State

      Maharashtra

    • Pin Code

      401506

    • Tel. No.

      66635456

    • Fax No.

      66635460

    • Email

      auro@aurolabs.com

    • Internet

      http://www.aurolabs.com

  • Registrars

    • Name

      Sharex Dynamic (India) Pvt. Ltd.

    • Address

      1st Floor, Safed Pool,Andheri Kurla Road,Andheri (E)

    • City

      Mumbai 400072

    • State

      Maharashtra

    • Tel. No.

      022-28515606, 28515644

    • Fax No.

      022-28512885

    • Email

      info@sharexindia.com

    • Internet

      http://www.sharexindia.com

  • Management

    • Name

      Designation

    • Sharat Deorah

      Chairman & Managing Director

    • Siddhartha Deorah

      Whole Time Director

    • Kavita Sharma

      Director

    • Kailash Chandra Bubna

      Independent Director

    • Govardhandas Aggarwal

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Auro Laboratories Ltd.

Auro Labs is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 530233.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Auro Laboratories Stock Price | Auro Labs Stock Quote | Auro Labs Results | Auro Labs News | View All Related Searches
Sections
Desktop Version »
Follow us on
Available On
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.